Sort
25,944 grants matching “neurodegeneration”
PASK-regulated genes and proteins as therapeutic targets for ALS and FTD
$752,319Daniel R Scoles · University Of Utah · R01 · FY2024 · NS
Effects of tDCS on spoken and written production in Primary Progressive Aphasia
$752,315Kyrana Tsapkini · Johns Hopkins University · R01 · FY2016 · DC
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial
$752,288Barry W Rovner · Thomas Jefferson University · R01 · FY2022 · AG
T cells in the aging brain
$752,242Anne Brunet · Stanford University · R01 · FY2021 · AG
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$752,131Elizabeth Head · University Of California-Irvine · R01 · FY2019 · AG
Mitochondria and metabolism in neurodegeneration
$751,972John William Elrod · Temple Univ Of The Commonwealth · R01 · FY2024 · NS
Mitochondria and metabolism in neurodegeneration
$751,972John William Elrod · Temple Univ Of The Commonwealth · R01 · FY2025 · NS
IMPACT OF ENERGY FAILURE ON ALPHA-SYNUCLEIN SPREAD AND NEURODEGENERATION
$751,936J.David Gladstone Institutes · · FY2022 · Department of the Army
Microglia antigen presentation in the CNS of Alzheimer's disease
$751,861Wassim Elyaman · Columbia University Health Sciences · R01 · FY2020 · AG
Discovery of Selective Inhibitors for the EphA4 Kinase
$751,756Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG
Project 1 - Biomarkers of Neurovascular Function
$751,684Berislav V Zlokovic · University Of Southern California · P01 · FY2022 · AG
Treating primary progressive aphasia and elucidating neurodegeneration in the language network using transcranial direct current stimulation
$751,595Roy H Hamilton · University Of Pennsylvania · R01 · FY2022 · AG
Reversal of HIV latency by METH and Inflammation
$751,522Jonathan Karn · Case Western Reserve University · R01 · FY2016 · DA
Monocyte CNS HIV entry & neurodegeneration: Translational studies in the CART era
$751,476Joan Weinberger Berman · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · MH
Optimization and preclinical evaluation of brain permeant SE-CRISPR to edit ApoE4 after IV infusion in AD models
$751,442Varghese John · University Of California Los Angeles · R01 · FY2025 · AG
Neuroprotective role of GLP-1 receptor agonists
$751,361Nigel H. Greig · National Institute On Aging · ZIA · FY2016 · AG
Image-based cerebrovascular network snythesis(iCNS) to model Alzheimer's Disease
$751,339Andreas A Linninger · University Of Illinois At Chicago · R01 · FY2023 · AG
Role of Neurotrophins in the Development of the Mammalian Nervous System
$751,233Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration
$751,212Gregory A Cox · Jackson Laboratory · R01 · FY2022 · NS
The Role of HIV Proteins in Psychostimulant Abuse
$751,112Aurelio Antonio Galli · University Of Alabama At Birmingham · R01 · FY2025 · DA
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease
$750,835Thomas Spurgeon Wingo · Emory University · R01 · FY2024 · AG
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease
$750,835Thomas Spurgeon Wingo · Emory University · R01 · FY2023 · AG
Development of molecular probe inhibitors of pathogenic, cytosolic cathespin B in traumatic brain injury and Alzheimers Disease neurodegeneration
$750,769Vivian Y. H. Hook · University Of California, San Diego · R01 · FY2020 · NS
Structural analysis of tau associated with parenchymal and vascular prion protein amyloidosis
$750,707Ruben Vidal · Indiana University Indianapolis · R01 · FY2024 · AG
Neurodegenerative and Neurodevelopmental Subcortical Shape Diffeomorphometry
$750,646Michael I Miller · Johns Hopkins University · R01 · FY2016 · EB